A detailed history of South Dakota Investment Council transactions in United Therapeutics Corp stock. As of the latest transaction made, South Dakota Investment Council holds 9,638 shares of UTHR stock, worth $3.45 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
9,638
Previous 9,638 -0.0%
Holding current value
$3.45 Million
Previous $3.07 Million 12.51%
% of portfolio
0.07%
Previous 0.06%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$228.26 - $319.04 $45,652 - $63,808
-200 Reduced 2.03%
9,638 $3.07 Million
Q1 2024

May 02, 2024

SELL
$210.76 - $249.51 $168,608 - $199,608
-800 Reduced 7.52%
9,838 $2.26 Million
Q3 2023

Nov 07, 2023

SELL
$211.82 - $248.24 $105,910 - $124,120
-500 Reduced 4.49%
10,638 $2.4 Million
Q2 2023

Aug 10, 2023

SELL
$205.19 - $232.99 $354,773 - $402,839
-1,729 Reduced 13.44%
11,138 $2.46 Million
Q1 2023

May 10, 2023

SELL
$212.99 - $276.17 $3.51 Million - $4.56 Million
-16,500 Reduced 56.19%
12,867 $2.88 Million
Q2 2022

Aug 11, 2022

SELL
$174.81 - $241.14 $2.84 Million - $3.91 Million
-16,229 Reduced 35.59%
29,367 $6.92 Million
Q1 2022

May 10, 2022

SELL
$166.16 - $213.96 $4.13 Million - $5.32 Million
-24,878 Reduced 35.3%
45,596 $8.18 Million
Q3 2021

Nov 09, 2021

SELL
$179.86 - $214.88 $449,650 - $537,200
-2,500 Reduced 3.43%
70,474 $13 Million
Q2 2021

Aug 11, 2021

BUY
$170.47 - $211.93 $272,752 - $339,088
1,600 Added 2.24%
72,974 $13.1 Million
Q1 2021

May 13, 2021

SELL
$153.94 - $174.85 $1.3 Million - $1.48 Million
-8,448 Reduced 10.58%
71,374 $11.9 Million
Q3 2020

Nov 06, 2020

SELL
$99.9 - $121.13 $211,788 - $256,795
-2,120 Reduced 2.59%
79,822 $8.06 Million
Q2 2020

Aug 13, 2020

SELL
$92.74 - $125.82 $457,208 - $620,292
-4,930 Reduced 5.68%
81,942 $9.92 Million
Q1 2020

May 11, 2020

BUY
$79.39 - $115.35 $523,338 - $760,387
6,592 Added 8.21%
86,872 $8.24 Million
Q4 2019

Feb 11, 2020

SELL
$78.31 - $95.34 $678,164 - $825,644
-8,660 Reduced 9.74%
80,280 $7.07 Million
Q3 2019

Nov 13, 2019

BUY
$74.85 - $85.99 $3.34 Million - $3.84 Million
44,640 Added 100.77%
88,940 $7.09 Million
Q2 2019

Aug 13, 2019

BUY
$76.06 - $120.81 $235,786 - $374,511
3,100 Added 7.52%
44,300 $3.46 Million
Q1 2019

May 03, 2019

SELL
$107.15 - $126.84 $21,430 - $25,368
-200 Reduced 0.48%
41,200 $4.84 Million
Q4 2018

Feb 06, 2019

BUY
$101.4 - $128.73 $50,700 - $64,364
500 Added 1.22%
41,400 $4.51 Million
Q3 2018

Nov 14, 2018

SELL
$113.81 - $129.46 $1.05 Million - $1.19 Million
-9,200 Reduced 18.36%
40,900 $5.23 Million
Q4 2017

Feb 09, 2018

SELL
$118.58 - $151.28 $806,344 - $1.03 Million
-6,800 Reduced 11.95%
50,100 $7.41 Million
Q3 2017

Nov 09, 2017

BUY
$114.6 - $136.81 $6.52 Million - $7.78 Million
56,900
56,900 $6.67 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track South Dakota Investment Council Portfolio

Follow South Dakota Investment Council and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

News

Stay updated on South Dakota Investment Council with notifications on news.